Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are uncommon but
clinically challenging and fascinating tumors. GEP-NETs present as either functional or as …

Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual incidence of
6.9/100 000. They arise from cells of the diffuse endocrine system, which are mainly …

Gastric neuroendocrine tumors (G-NET) are rare tumors arising from enterochromaffin-like
cells of the gastric mucosa. They belong to a larger group called gastroenteropancreatic …

The incidence of neuroendocrine tumors (NETs) has increased in the last decades. Surgical
treatment encompasses a panel of approaches ranging from conservative procedures to …

The small intestine and pancreas are among the most frequent abdominal sites of origin of
neuroendocrine tumours. Distinctive features of these forms are represented by the relatively …

Neuroendocrine tumors (NETs) are rare neoplasms of the gastroenteropancreatic tract. As a
result, these tumors tend to be discovered incidentally, on either radiologic or pathologic …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and complex
neoplasms that present many clinical challenges. Most GEP-NETs are sporadic, but they …

Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …

Summary Background Neuroendocrine tumours (NETs) of the stomach and duodenum are
rare, but are increasing in incidence. Optimal management of localised, low‐grade gastric …

The name neuroendocrine tumours (NETs), or the synonyme gastroenteropancreatic
neuroendocrine tumours (GEP-NETs), is used to depict tumours with origin in …